Health Populi
OCTOBER 31, 2018
It’s important to note that 79% of consumers support the idea of medical devices and sensors that immediately transmit significant changes to peoples’ doctors, as the bar chart from Unisys’s consumer survey data illustrates. Risk management for cybersecurity in healthcare touches finance, quality and reputation alike.
HIT Consultant
MARCH 31, 2022
What You Should Know: – 4C Medical Technologies , a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease raises $35.4M in Series C funding was led by MicroPort CardioFlow Medtech Corporation (HKEX:2160).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
APRIL 8, 2024
What You Should Know: – Model N (NYSE: MODN), a leading provider of revenue optimization and compliance solutions for the life sciences and high-tech industries, has announced a definitive agreement to be acquired by Vista Equity Partners (“Vista”). per share in an all-cash transaction valued at approximately $1.25
Health Business Group
FEBRUARY 8, 2024
This conversation traces his path from academic research at Johns Hopkins University to becoming a key figure in medical technology innovation, highlighting the transition of pathology from traditional methods to digital solutions.
HIT Consultant
SEPTEMBER 6, 2023
Pitango believes that the most promising healthcare innovations occur at the convergence of life science and medical technologies with data science and AI, coupled with innovative services. The fund’s investment strategy is focused on all segments of healthcare and life sciences.
HIT Consultant
SEPTEMBER 1, 2021
With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as life sciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes. About Manan Sheth.
Healthcare ECONOMIST
MAY 30, 2023
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries.
Expert insights. Personalized for you.
85 
Let's personalize your content